knowledge -WSS

knowledge

author：hotspot 2025-08-12 13:38:42 - browse：97

Becton Dickinson plans to pay $4.2 billion for Edwards Lifesciences’ critical care business, which sells technology that monitors the heart conditions of critically ill patients.

Edwards had told investors in December 2023 that it planned to spin off the business in order to focus more sharply on addressing structural defects in the heart. BD, meanwhile, wants to increase its monitoring presence in hospitals. In a statement announcing the acquisition, the company touted the “advanced AI algorithms” used in Edwards’ monitors.

BD CEO Tom Polen said in a statement that the acquisition will bolster BD’s portfolio of “AI-enabled clinical decision tools” and digital health products in general.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： How to make over

hotspot

WSS

How the drug

Kellogg’s is going to war over Mexico’s nutrition label rules

Health officials lay out plans to cope with respiratory virus season

FDA advisory panel to debate high blood pressure devices

ALS advocates say criticism of new drugs misses bigger picture

Ethical issues complicate the benefits of medical crowdfunding

Wikipedia

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Alkermes shareholders re

Crinetics acromegaly drug succeeds in late

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What American doctors can learn from their Israeli counterparts

Affirmative action in medical school literally saved lives

PBMs are inflating the cost of generic drugs. They must be reined in

Hepatitis C has a cure — but many Americans still lack access to it

Wegovy improves function in certain heart failure patients

Moonlake's readout produced a cash windfall. Risks remain

Humana sues Biden admin over Medicare Advantage audit rule

leisure time

What American doctors can learn from their Israeli counterparts

Roche's accidental data boosts hopes for anti

Weighted lottery helped low

Hospital at home shows how to bring innovation to health care

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Covid hospitalizations on the rise, Humana says

hotspot

hotspot

knowledge

leisure time